Leqembi is an FDA approved drug to treat Alzheimer’s disease. To be eligible to receive Leqembi, patients will require cognitive testing that establishes a diagnosis of Mild Alzheimer’s disease. Our office offers a rapid assessment and report to help determine a patient’s eligibility to receive this drug as soon as possible, often within weeks of receiving the referral.

To schedule an evaluation for yourself or a loved one, please call 415-877-4408. To refer a patient, please fax a referral to 415-877-4470 and we will contact the patient accordingly. For questions about Leqembi assessments, please email us at info@californiabrainhealth.com.